Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jeff A. Guderian
Observed names:
J Guderian,
Jeff Guderian
Institution:
Infectious Disease Research Institute
Observed institutions:
Infectious Disease Research Institute,
American Red Cross,
University of Washington,
Corixa Corporation,
Fred Hutch Cancer Center,
InBios International (United States),
University of Chile
show all 7
ORCID:
0000-0001-9666-5397
Observed ORCID:
0000-0001-9666-5397
OpenAlex ID:
A5043211549
Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
2011
·
Rhea N. Coler
, Sylvie Bertholet
, et al.
·
PLoS ONE
·
312
PDF
A Nanostructured Lipid Carrier for Delivery of a Replicating Viral RNA Provides Single, Low-Dose Protection against Zika
2018
·
Jesse H. Erasmus
, Amit P. Khandhar
, et al.
·
Molecular Therapy
·
161
PDF
Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia
1993
·
TP Jr Loughran
, R Zambello
, et al.
·
Blood
·
45
PDF
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
2021
·
Susan L. Baldwin
, Valerie A. Reese
, et al.
·
PLoS ONE
·
35
PDF
Cloning of aMycobacterium tuberculosisGene Encoding a Purifed Protein Derivative Protein That Elicits Strong Tuberculosis‐Specific Delayed‐Type Hypersensitivity
2000
·
Rhea N. Coler
, Yasir A. W. Skeiky
, et al.
·
The Journal of Infectious Diseases
·
31
PDF
Lateral Flow Immunoassay for Diagnosis of Trypanosoma cruzi Infection with High Correlation to the Radioimmunoprecipitation Assay
2009
·
Raymond L. Houghton
, Yvonne Y. Stevens
, et al.
·
Clinical and Vaccine Immunology
·
28
Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved In Vitro Th1-Type Cytokine Recall Responses in Human Whole Blood
2020
·
Babatunde Ayodeji Adeagbo
, Akintunde Oluseto Akinlalu
, et al.
·
ACS Omega
·
7
Modulating Potency: Physicochemical Characteristics are a Determining Factor of TLR4-Agonist Nanosuspension Activity
2014
·
Quinton M. Dowling
, Sandra J. Sivananthan
, et al.
·
Journal of Pharmaceutical Sciences
·
7
Show more works
View as search
Works count:
10
Citation count:
626
H-index:
7
I10-index:
6
Year
Topic
Type